1. Home
  2. CCCC vs DCGO Comparison

CCCC vs DCGO Comparison

Compare CCCC & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • DCGO
  • Stock Information
  • Founded
  • CCCC 2015
  • DCGO 2015
  • Country
  • CCCC United States
  • DCGO United States
  • Employees
  • CCCC N/A
  • DCGO N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • DCGO Managed Health Care
  • Sector
  • CCCC Health Care
  • DCGO Health Care
  • Exchange
  • CCCC Nasdaq
  • DCGO Nasdaq
  • Market Cap
  • CCCC 304.8M
  • DCGO 315.9M
  • IPO Year
  • CCCC 2020
  • DCGO N/A
  • Fundamental
  • Price
  • CCCC $6.86
  • DCGO $3.46
  • Analyst Decision
  • CCCC Buy
  • DCGO Strong Buy
  • Analyst Count
  • CCCC 7
  • DCGO 5
  • Target Price
  • CCCC $8.71
  • DCGO $6.10
  • AVG Volume (30 Days)
  • CCCC 2.4M
  • DCGO 1.1M
  • Earning Date
  • CCCC 08-06-2024
  • DCGO 08-05-2024
  • Dividend Yield
  • CCCC N/A
  • DCGO N/A
  • EPS Growth
  • CCCC N/A
  • DCGO N/A
  • EPS
  • CCCC N/A
  • DCGO 0.20
  • Revenue
  • CCCC $20,036,000.00
  • DCGO $703,373,468.00
  • Revenue This Year
  • CCCC $26.24
  • DCGO $1.59
  • Revenue Next Year
  • CCCC N/A
  • DCGO N/A
  • P/E Ratio
  • CCCC N/A
  • DCGO $17.13
  • Revenue Growth
  • CCCC N/A
  • DCGO 61.46
  • 52 Week Low
  • CCCC $1.06
  • DCGO $2.75
  • 52 Week High
  • CCCC $11.88
  • DCGO $10.82
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 70.41
  • DCGO 65.44
  • Support Level
  • CCCC $4.36
  • DCGO $2.75
  • Resistance Level
  • CCCC $7.66
  • DCGO $3.06
  • Average True Range (ATR)
  • CCCC 0.51
  • DCGO 0.15
  • MACD
  • CCCC 0.33
  • DCGO 0.06
  • Stochastic Oscillator
  • CCCC 75.79
  • DCGO 97.26

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.

Share on Social Networks: